Amit Sachdev
At a glance: Amit Sachdev is Evp Chief Patient & Ext Af Off at Vertex Pharmaceuticals (VRTX). Their latest SEC Form 4, filed Feb 26, 2026, reported a sale of $898K. On file: 0 purchase lines ($0) and 9 sale lines ($28.4M).
Disclosed holdings: about $29.0M of VRTX stock: 55,570 shares reported on their latest Form 4 (filed Feb 26, 2026), valued at the Nov 19, 2026 close of $521.30. This counts only VRTX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Evp Chief Patient & Ext Af Off at Vertex Pharmaceuticals Inc / Ma (VRTX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Amit Sachdev's InsiderPrint
9 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 9 times a year, typically $2.0M a trade; most sales are on a pre-planned 10b5-1 schedule; trades in the same month most years.
- Bump outward: a purchase (0)
- Dent inward: a sale (9)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Mark ZuckerbergCEO · META · 100% match
- Edward Grunde McLaughlinCTO, President · MA · 100% match
- Satya NadellaCEO · MSFT · 100% match
- Jennifer K. MannPresident · KO · 99% match
- Jeffrey HenleyChair · ORCL · 99% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Feb 26SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 1,84655,570 held (−3%) | $486.35 | $898K | +7.2% |
| Feb 23SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 920116,627 held (−1%) | $463.91 | $427K | +12.4% |
| Feb 23SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 2,730113,897 held (−2%) | $465.05 | $1.3M | +12.1% |
| Feb 23SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 1,848112,049 held (−2%) | $465.80 | $861K | +11.9% |
| Feb 23SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 10,263101,786 held (−9%) | $467.75 | $4.8M | +11.4% |
| Feb 23SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 19,66282,124 held (−19%) | $468.57 | $9.2M | +11.3% |
| Feb 23SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 7,24174,883 held (−9%) | $469.61 | $3.4M | +11.0% |
| Feb 23SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 11,71263,171 held (−16%) | $470.54 | $5.5M | +10.8% |
| Feb 23SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 4,23758,934 held (−7%) | $471.43 | $2.0M | +10.6% |
- Sell
Evp Chief Patient & Ext Af Off Amit Sachdev sold $898K of VRTX at $486.35 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp Chief Patient & Ext Af Off Amit Sachdev sold $427K of VRTX at $463.91 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp Chief Patient & Ext Af Off Amit Sachdev sold $1.3M of VRTX at $465.05 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp Chief Patient & Ext Af Off Amit Sachdev sold $861K of VRTX at $465.80 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp Chief Patient & Ext Af Off Amit Sachdev sold $4.8M of VRTX at $467.75 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp Chief Patient & Ext Af Off Amit Sachdev sold $9.2M of VRTX at $468.57 — pre-scheduled 10b5-1 plan sale.
Follow Amit Sachdev
Get one email when Amit Sachdev files a new purchase or sale. Free.
At most one email a day about Amit Sachdev, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.